Doxorubicin-loaded galactose-conjugated poly(d,l-lactide-co-glycolide) nanoparticles as hepatocyte-targeting drug carrier

References

• Bicho A, Peça IN, Roque ACA, Cardoso MM. Anti-CD8 conjugated nanoparticles to target mammalian cells expressing CD8. Int J Pharmaceut, 2010;399(1–2):80–6.
   PubMed Web of Science ®Google Scholar
• Brannon-Peppas L, Blanchette JO. Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliv Rev, 2004;56(11):1649–59.
   PubMed Web of Science ®Google Scholar
• Craparo EF, Triolo D, Pitarresi G, Giammona G, Cavallaro G. Galactosylated micelles for a ribavirin prodrug targeting to hepatocytes. Biomacromolecules, 2013;14:1838–49.
   PubMed Web of Science ®Google Scholar
• Duncan R, Seymour LCW, Scarlett L, Lloyd JB, Rejmanova P, Kopecek J. Fate of N-(2-hydroxypropyl)methacrylamide copolymers with pendant galactosamine residues after intravenous administration to rats. Biochim Biophys Acta, 1986;880:62–71.
   PubMed Web of Science ®Google Scholar
• Hashida MAK, Nishikawa M, Yamashita F, Takakura Y, Liu HM, Nakamura M. Design of polymeric prodrugs of prostaglandin E(1) having galactose residue for hepatocyte targeting. J Control Release, 1999;62:253–62.
   PubMed Web of Science ®Google Scholar
• Hirose HIH, Uchiyama M, Cho CS, Akaike T. Regulation of asialoglycoprotein receptor expression in the proliferative state of hepatocytes. Biochem Biophys Res Commun, 2001;287:675–81.
   PubMed Web of Science ®Google Scholar
• Jeong YI, Seo SJ, Park IK, Lee HC, Kang IC, Akaike T, Cho CS. Cellular recognition of paclitaxel-loaded polymeric nanoparticles composed of poly(gamma-benzyl L-glutamate) and poly(ethylene glycol) diblock copolymer endcapped with galactose moiety. Int J Pharmaceut, 2005;296(1–2):151–61.
   PubMed Web of Science ®Google Scholar
• Lai CH, Lin CY, Wu HT, Chan HS, Chuang YJ, Chen CT, Lin CC. Galactose encapsulated multifunctional nanoparticle for HepG2 cell internalization. Adv Funct Mater, 2010;20(22):3948–58.
   Web of Science ®Google Scholar
• Li C, Zhang D, Guo Y, Guo H, Li T, Hao L, Zheng D, Liu G, Zhang Q. Galactosylated bovine serum albumin nanoparticles for parenteral delivery of oridonin: Tissue distribution and pharmacokinetic studies. J Microencapsul, 2014;31(6):573–8.
   PubMed Web of Science ®Google Scholar
• Liang HF, Chen CT, Chen SC, Kulkarni AR, Chiu YL, Chen MC, Sung HW. Paclitaxel-loaded poly(gamma-glutamic acid)-poly(lactide) nanoparticles as a targeted drug delivery system against cultured HepG2 cells. Bioconjugate Chem, 2006;17:291–9.
   PubMed Web of Science ®Google Scholar
• Meijer DKF, Vandersluijs P. Covalent and noncovalent protein binding of drugs: implications for hepatic clearance, storage, and cell-specific drug delivery. Pharm Res, 1989;6:105–18.
   PubMed Web of Science ®Google Scholar
• Mitsuaki G, Hirohumi Y, Chang C, Kobayashi A, Shinoda T, Maeda A, Kojima S, Kobayashi A, Aikaike T. Lactose-carrying plystyrene as a drug delivery carrier-investigation of body distribution to parenchymal liver-cells using I-125 labeled lactose-carrying polystyrene. J Control Release, 1994;28:223–33.
   Web of Science ®Google Scholar
• Moghimi SM, Hunter AC, Murray JC. Long-circulating and target-specific nanoparticles: Theory to practice. Pharmacol Rev, 2001;53(2):283–318.
   PubMed Web of Science ®Google Scholar
• Monneret C. Recent developments in the field of antitumour anthracyclines. Eur J Med Chem, 2001;36:483–93.
   PubMed Web of Science ®Google Scholar
• Nishikawa M, Kamiju A, Fujita T, Takakura Y, Sezaki H, Hashida M. Synthesis and pharmacokinetics of a new liver-specific carrier, glycosylated carboxymethyl-dextran, and its application to drug targeting. Pharm Res, 1993;10:1253–61.
   PubMed Web of Science ®Google Scholar
• O’Hare KB, Hume IC, Scarlett L, Chytry V, Kopeckova P, Kopecek J, Duncan R. Effect of galactose on interaction to N-(2-hydroxypropyl)methacrylamide copolymers. with hepatoma cells in culture – Preliminary application to an anticancer agent, daunomycin. Hepatology, 1989;10:207–14.
   PubMed Web of Science ®Google Scholar
• Peça IN, Petrova KT, Cardoso MM, Barros MT. Preparation and characterization of polymeric nanoparticles composed of poly(DL-lactide-coglycolide) and poly(DL-lactide-co-glycolide)-co-poly(ethylene glycol) 10%Triblock end-capped with a galactose moiety. React Funct Polym, 2012;72(1):729–35.
   Web of Science ®Google Scholar
• Perrin DD, Armarego WLF, Perrin DR. 1980. Purification of laboratory chemicals. Oxford, New York: Pergamon Press.
   Google Scholar
• Ritger PL, Peppas NA. A simple equation for description of solute release II. Fickian and anomalous release from swellable devices. J Control Release, 1987;5(1):37–42.
   Google Scholar
• Shi Y, Zhou M, Zhang J, Lu W. Preparation and cellular targeting study of VEGF-conjugated PLGA nanoparticles. J Microencapsul, 2015;32(7):699–704.
   PubMed Web of Science ®Google Scholar
• Wands JR, Blum HE. Primary hepatocellular carcinoma. N Engl J Med, 1991;325:729–31.
   PubMed Web of Science ®Google Scholar
• Ward CM, Read ML, Seymour LW. Systemic circulation of poly(L-lysine)/DNA vectors is influenced by polycation molecular weight and type of DNA: differential circulation in mice and rats and the implications for human gene therapy. Blood, 2001;97:2221–9.
   PubMed Web of Science ®Google Scholar
• Wu GY, Wu CH. Evidence for targeted gene delivery to Hep G2 hepatoma cells in vitro. Biochemistry, 1988;27:887–92.
   PubMed Web of Science ®Google Scholar
• Yang J, Wang F, Tian LL, Su J, Zhu XQ, Lin L, Ding XR, Wang XJ, Wang SQ. Fibronectin and asialoglyprotein receptor mediate hepatitis B surface antigen binding to the cell surface. Arch Virol, 2010;155(6):881–8.
   PubMed Web of Science ®Google Scholar
• Yeh TH, WU FLL, Shen LJ. Intracellular delivery of cytochrome c by galactosylated albumin to hepatocarcinoma cells. J Drug Target, 2014;22(6):528–35.
   PubMed Web of Science ®Google Scholar
• Yu CY, Wang YM, Li NM, Liu GS, Yang S, Tang GT, He DX, Tan XW, Wei H. In vitro and in vivo evaluation of pectin-based nanoparticles for hepatocellular carcinoma drug chemotherapy. Mol Pharm, 2014;11(2):638–44.
   PubMed Web of Science ®Google Scholar